Indian pharmaceutical companies have suspended work due to the spread of the coronavirus

Indian the largest sector for production of drugs was closed due to the spread of COVID-19. The pharmaceutical plants located in sector Baddi, Himachal Pradesh, forced to stop or significantly reduce the work as it was in the quarantine area, says FiercePharma.

It is known that the work stopped 50 pharmaceutical companies, including Sun Pharmaceuticals plant, a production site Dr. Reddy’s operates at 15% capacity, the plant of the Abbott – 25-30%, while Cadila – 35%.

Although these pharmaceutical companies also have factories in other parts of India and even in other countries, the possible impact of quarantine on the supply chain of drugs has attracted the attention of the FDA. Generic the US market is heavily dependent on the supply of medicines from China and India. To prevent shortages of drugs, the FDA has temporarily allowed hospitals to buy from pharmacy production of drugs intended for the treatment of patients with severe COVID-19.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]